Samsung Life Insurance Co., Ltd. (KRX:032830) earned ₩727.4bn of net income in the second quarter of 2026. It reported ₩63.66tn of total comprehensive income over the same three months.
Total equity went from ₩33.66tn at June 30, 2025 to ₩146.96tn at June 30, 2026. Four and a third times, in a year, at a company whose insurance operations produced under ₩2tn of profit across the period.
Where it came from is not a mystery, and the arithmetic is worth doing because it turns out to be almost exact.
Samsung Electronics closed at ₩119,900 on December 30, 2025 and ₩334,000 on June 30, 2026. That's a gain of ₩214,100 a share, or 178.6%, in six months.
Samsung Life is generally reported to hold about 8.5% of Samsung Electronics. Against the 5,846,278,608 shares outstanding at June 30, that is roughly 497 million shares. Multiply by the price gain and you get about ₩106.4tn of pre-tax appreciation. Take off Korean corporate tax at roughly 25%, which the company must book as a deferred liability against unrealised gains, and you are left with about ₩79.8tn.
Samsung Life's equity rose ₩82.12tn over the same six months.
Those two figures are close enough that the conclusion is unavoidable: the Samsung Electronics holding explains essentially the entire change in this company's book value. Everything else the insurer did over half a year, across ₩460tn of assets, is a rounding error next to one line item.
The balance sheet shows the same thing from the other side. Total assets went from ₩350.69tn to ₩460.32tn, up ₩109.6tn. Total liabilities went from ₩285.85tn to ₩313.36tn, up ₩27.5tn, which is about 25% of the asset increase and is consistent with deferred tax being booked against the gain.
One small bonus for Samsung Life along the way: Samsung Electronics reduced its own share count from 5,919,637,922 to 5,846,278,608 over the same six months, retiring 73,359,314 shares. That lifts Samsung Life's ownership percentage without it buying anything.
Now run the same calculation forward.
Samsung Electronics closed at ₩266,000 on August 27. That is ₩68,000 below the June 30 mark, a decline of 20.4%, in under two months.
On roughly 497 million shares, that's about ₩33.8tn of pre-tax value gone, or something near ₩25tn after the deferred tax reverses. Samsung Life's ₩146.96tn of reported equity is, on that arithmetic, already closer to ₩122tn.
None of it will appear in net income. Under IFRS 9, equity investments designated at fair value through other comprehensive income never recycle through profit and loss, not on the way up and not on the way down and not on sale. The loss will show up in third-quarter comprehensive income, in a line most investors skip, and the reported earnings will look untouched.
That is the single most important thing to understand about this company's accounts. Its book value is a leveraged, quarterly-marked position in one share price, and the income statement will never tell you about it.
At the August 27 close of ₩307,000 across 200,000,000 shares, Samsung Life is capitalised at ₩61.40tn.
Against June's reported book of ₩146.96tn that is 0.42 times. Against my rough August estimate of ₩122tn it is about 0.50 times.
Try it a third way. Roughly 497 million Samsung Electronics shares at ₩266,000 are worth about ₩132.2tn. Samsung Life's entire market capitalisation is 46% of the market value of that one holding, before counting a life insurance business with ₩460tn of assets, ₩22.9tn of retained earnings, and ₩2.45tn of net income in FY2025.
Put crudely, the market is offering you Korea's largest life insurer at less than half the value of the Samsung Electronics shares it owns, and throwing in the insurance company.
Four reasons, and they are cumulative.
The stake cannot be sold. It is the mechanism by which the Lee family controls Samsung Electronics, running through Samsung C&T to Samsung Life to Samsung Electronics. Selling it would end that arrangement, so it will not happen voluntarily. A holding that will never be monetised is worth less to a minority shareholder than to an owner.
The tax is real and already partly booked. Any actual disposal would crystallise Korean corporate tax on an enormous embedded gain accumulated over decades, and the deferred liability sitting in that ₩27.5tn increase in liabilities is the accounting acknowledgement of it.
Regulatory capital does not benefit as much as book value suggests. Korean insurers are supervised on the K-ICS solvency framework, which applies its own treatment to equity holdings and does not simply hand a company credit for a marked-up affiliate stake. The half-year report contains the ratio; the summary financials do not.
And the volatility is punishing. This book value fell ₩25tn or so in eight weeks. An investor buying at book would have paid for something that evaporated before the statements were even filed.
The one that would change everything is legislative.
Korea's Insurance Business Act limits an insurer's holdings of affiliate securities to a share of total assets, and it currently measures those holdings at acquisition cost. Samsung Life bought its Samsung Electronics shares decades ago, so at cost the stake is trivially small and comfortably inside the limit.
Bills to change that measure to fair value have been introduced in the National Assembly repeatedly over more than a decade, to the point that they are informally named after this company. None has passed.
If one did, the arithmetic is brutal. Three percent of ₩460tn of assets is under ₩14tn. The stake at market is around ₩132tn. Samsung Life would have to dispose of the great majority of it, which means putting something like 7% of Samsung Electronics into the market and dismantling the group's control chain in the process.
That would be catastrophic for the Samsung group's governance and, arguably, enormously good for a Samsung Life minority shareholder, who would receive a company sitting on an ocean of realised cash. It is precisely because both of those are true that the bill has never passed, and precisely because it might that the discount exists.
I have no view on whether it happens. Nobody does. What I would say is that a large part of what you are buying at 0.42 times book is an option on Korean politics, and options with no expiry date and no probability you can estimate are hard to size.
The National Assembly, not the earnings. Any Insurance Business Act amendment reaching committee stage would move this stock more than a decade of insurance results.
Failing that, the third-quarter comprehensive income line, filed in November. It should show a large negative number reflecting the Samsung Electronics decline from ₩334,000 to wherever the quarter ends, and the size of it will confirm or refute the roughly 8.5% stake assumption this analysis rests on. If the OCI hit is materially smaller than the arithmetic implies, Samsung Life has hedged or the holding is smaller than reported, and either would be news.
kstock reads DART every morning and writes up what moved — the contract, the buyback, the number that does not add up. The daily post and a Saturday roundup, by email.